(−)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
- 15 May 1996
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 303 (3) , 183-186
- https://doi.org/10.1016/0014-2999(96)00185-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major DepressionJournal of Clinical Psychopharmacology, 1995
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis studyEuropean Journal of Pharmacology, 1993
- Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5‐HT1A agonistsSynapse, 1993
- 5-HT and antidepressants: new views from microdialysis studiesTrends in Pharmacological Sciences, 1993
- Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptorsNeuropharmacology, 1993
- Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis StudyJournal of Neurochemistry, 1993
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988